Classification of participants with mild platelet-based bleeding defects
| Type of platelet defect . | No. of participants . | % of participants . |
|---|---|---|
| Membrane Gi signaling | 21 | 32.8% |
| TxA2 pathway | 14 | 21.9% |
| GPVI | 4 | 6.2% |
| Gq | 1 | 1.6% |
| Dense granule | 19 | 29.7% |
| Complex | 5 | 7.8% |
| Total | 64 | 100% |
| Type of platelet defect . | No. of participants . | % of participants . |
|---|---|---|
| Membrane Gi signaling | 21 | 32.8% |
| TxA2 pathway | 14 | 21.9% |
| GPVI | 4 | 6.2% |
| Gq | 1 | 1.6% |
| Dense granule | 19 | 29.7% |
| Complex | 5 | 7.8% |
| Total | 64 | 100% |
Participants who exhibited a defect in platelet function were subdivided on the basis of their major platelet phenotype, as described in the text.